Viewing Opinion | StockChase
Celgene Corp (CELG-Q) opinion on 2017-05-19

Last Price Recorded: 104.1000 on 2017-11-17

ON STOCKCHASE SINCE Jan 2012

Consumer Products
DON'T BUY

John Petrides
Celgene Corp was $116.930 at time of opinion
Owned : No

Trading at 25X price to cash flow, a bit too rich for him. The stock is up 17% over the last 12 months. The bet on this company is that you have faith in their pipeline executing on future drugs. There is much more attractive value in healthcare outside of this.

BULLISH

All opinions for CELG-Q (52)

4 BUY
2 BUY on WEAKNESS
8 COMMENT
4 DON'T BUY
3 HOLD
1 PARTIAL BUY
11 PAST TOP PICK
1 SELL
16 TOP PICK
1 WAIT
1 WATCH
View All

More experts covering CELG-Q

SAVE
Add CELG-Q to Watch List

All opinions for CELG-Q (52)

4 BUY
2 BUY on WEAKNESS
8 COMMENT
4 DON'T BUY
3 HOLD
1 PARTIAL BUY
11 PAST TOP PICK
1 SELL
16 TOP PICK
1 WAIT
1 WATCH
View All

More experts covering CELG-Q

SAVE
Add CELG-Q to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company